|
End-of-day quote
Taipei Exchange
2026-09-22
|
5-day change | 1st Jan Change | ||
| 7.050 TWD | +0.71% |
|
-1.40% | -28.79% |
| 08-12 | Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-28 | Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHARMIGENE, INC. | Bio Diagnostics & Testing | +0.71% | -1.40% | -28.79% | -40.76% | -68.24% | 11.13M |
-
|
-
|
-
|
- Stock Market
- Stocks
- 7595 Stock
- Charts Pharmigene, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
